Exome sequencing is an effective strategy for identifying human disease genes. However,
this methodology is difficult in late-onset diseases where limited availability of DNA from …

Purpose: To determine the frequency of abnormalities in human leukocyte antigen (HLA)
and antigen processing machinery (APM) component expression in malignant brain tumors. …

Background Mutations in the FUS gene have recently been discovered to be a major cause
of familial amyotrophic lateral sclerosis (FALS). Objective To determine the identity and …

Recent studies suggest that Cu/Zn superoxide dismutase (SOD1) could be pathogenic in
both familial and sporadic amyotrophic lateral sclerosis (ALS) through either inheritable or …

Background Delirium may be one of the presenting symptoms of COVID-19, complicating
diagnosis and care of elderly patients with dementia. We aim to identify the prevalence and …

The actual role of SARS‐CoV‐2 in brain damage remains controversial due to lack of
matched controls. We aim to highlight to what extent is neuropathology determined by SARS‐CoV‐…

Because drug transporters such as P-glycoprotein, the product of the multidrug resistance (MDR1)
gene, contribute to the function of the blood–brain barrier, we hypothesized that …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that affects central
and peripheral motor neuron cells. Its etiology is unknown, although a relationship between …

Background: Acute disseminated encephalomyelitis (ADEM) refers to a monophasic acute
multifocal inflammatory CNS disease. However, both relapsing and site-restricted variants, …

Identification of mutations at familial loci for amyotrophic lateral sclerosis (ALS) has provided
novel insights into the aetiology of this rapidly progressing fatal neurodegenerative disease. …